Please Wait
Applying Filters...
Xls
2D Structure
Also known as: Ly3537982, C2vj83psn7, Ly-3537982, Refchem:1093882, 2771246-13-8, Kras g12c inhibitor 19
Molecular Formula
C25H19ClF2N4O3S
Molecular Weight
529.0  g/mol
InChI Key
OZUPICRWMLEFCS-LBPRGKRZSA-N
FDA UNII
C2VJ83PSN7

Olomorasib is an orally available inhibitor of the oncogenic KRAS substitution mutation, G12C, with potential antineoplastic activity. Upon oral administration, olomorasib selectively targets the KRAS G12C mutant and inhibits KRAS G12C mutant-dependent signaling. KRAS, a member of the RAS family of oncogenes, serves an important role in cell signaling, division and differentiation. Mutations of KRAS may induce constitutive signal transduction leading to tumor cell growth, proliferation, invasion, and metastasis.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(13aS)-10-chloro-8-fluoro-6-oxo-2-prop-2-enoyl-1,3,4,12,13,13a-hexahydropyrazino[2,1-d][1,5]benzoxazocin-9-yl]-2-amino-7-fluoro-1-benzothiophene-3-carbonitrile
2.1.2 InChI
InChI=1S/C25H19ClF2N4O3S/c1-2-18(33)31-6-7-32-12(11-31)5-8-35-22-14(25(32)34)9-17(28)20(21(22)26)13-3-4-16(27)23-19(13)15(10-29)24(30)36-23/h2-4,9,12H,1,5-8,11,30H2/t12-/m0/s1
2.1.3 InChI Key
OZUPICRWMLEFCS-LBPRGKRZSA-N
2.2 Other Identifiers
2.2.1 UNII
C2VJ83PSN7
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Ly3537982

2. C2vj83psn7

3. Ly-3537982

4. Refchem:1093882

5. 2771246-13-8

6. Kras G12c Inhibitor 19

7. 2649788-46-3

8. 2-amino-4-[(4as)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1h,12h-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluorobenzo[b]thiophene-3-carbonitrile

9. 4-((s)-3-acryloyl-8-chloro-10-fluoro-12-oxo-2,3,4,4a,5,6-hexahydro-1h,12h-benzo[b]pyrazino[1,2-e][1,5]oxazocin-9-yl)-2-amino-7-fluorobenzo[b]thiophene-3-carbonitrile

10. Olomorasib [inn]

11. Orb1690700

12. Schembl23496727

13. Ex-a6653

14. Nsc853962

15. Akos040757943

16. Nsc-853962

17. Da-64768

18. Hy-132980

19. Cs-0311440

20. F78016

21. 2-amino-4-[(4as)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1h,12h-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-benzo[b]thiophene-3-carbonitrile

22. 2-amino-4-[(4r)-8-chloro-10-fluoro-12-oxo-3-(prop-2-enoyl)-2,3,4,4a,5,6-hexahydro-1h,12h-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-1-benzothiophene-3-carbonitrile

23. 4-[(13as)-10-chloro-8-fluoro-6-oxo-2-prop-2-enoyl-1,3,4,12,13,13a-hexahydropyrazino[2,1-d][1,5]benzoxazocin-9-yl]-2-amino-7-fluoro-1-benzothiophene-3-carbonitrile

24. Benzo[b]thiophene-3-carbonitrile, 2-amino-4-[(4as)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1h,12h-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-, (4r)-

2.4 Create Date
2021-08-21
3 Chemical and Physical Properties
Molecular Weight 529.0 g/mol
Molecular Formula C25H19ClF2N4O3S
XLogP34.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count2
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area128
Heavy Atom Count36
Formal Charge0
Complexity952
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1